Viracta Therapeutics

84 articles with Viracta Therapeutics

• Viracta Announces Scientific Advisory Board Formation

  9/25/2018

  Viracta Therapeutics, Inc., a clinical-stage drug development company advancing innovative approaches to treat viral-associated cancers and other serious diseases, announced the formation of its inaugural Scientific Advisory Board.

• Viracta Announces Scientific Advisory Board

  9/25/2018

  Viracta Therapeutics, Inc. announced the formation of its inaugural Scientific Advisory Board.

• NantKwest And Viracta Therapeutics Announce Series B Financing And Immunotherapy Partnership

  4/4/2017

• Viracta Therapeutics Acquires Phase II Epigenetic Drug Candidate From Chroma Therapeutics

  11/30/2016